Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Puma Biotechnology, Inc. logo — At Puma Biotechnology, our focus is on bringing innovative t...

Puma Biotechnology, Inc.

At Puma Biotechnology, our focus is on bringing innovative therapies to patients to enhance cancer care.

Founded 2010 United States Los Angeles, United States 244 employees Post Ipo Equity Total: $809.30M Biotechnology, Health and Wellness

General Information

Company Name Puma Biotechnology, Inc.
Founded Year 2010
Location United States Los Angeles, United States +1
Founders / Decision Makers
Team member
Employees 244
Industries Biotechnology, Health and Wellness
Funding Stage Post Ipo Equity
Social

Get notified when Puma Biotechnology, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Puma Biotechnology, Inc.

Puma Biotechnology, Inc. is a biotechnology company founded in 2010 and headquartered in the United States. The company's slogan "At Puma Biotechnology, our focus is on bringing innovative therapies to patients to enhance cancer care" reflects its commitment to innovation in cancer treatment. Puma Biotechnology is dedicated to the HER2+ breast cancer community and is passionate about evaluating options that may benefit patients across the breast cancer therapy spectrum. Recently, the company received a $10.00M Post-IPO Equity investment on 10 March 2022 from Athyrium Capital Management and Alan H. Auerbach. With its focus on innovative therapies and recent investment, Puma Biotechnology is well-positioned to make significant contributions to cancer care.

Taxonomy: Puma Biotechnology, cancer care, HER2+ breast cancer, therapies, innovative treatments, patient-centric approach, breast cancer therapy, oncology, pharmaceutical industry, clinical trials, precision medicine, patient advocacy, medical innovation

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 2
Investor
•••• •••• 		10 Mar 2022
Post-IPO Debt •••••• 2
Investor Investor
26 Jul 2021
Post-IPO Equity •••••• 2 •••• •••• 02 Nov 2017
Post-IPO Equity •••••• - 25 Oct 2016
Post-IPO Equity •••••• - 27 Jan 2015

View All 7 Funding Rounds

Puma Biotechnology, Inc. Alternatives & Competitors

Puma Biotechnology, Inc. vs
Elizabeth Wende Breast Care
Elizabeth Wende Breast Care United States

Breast Imaging Excellence Since 1975

54 employees
Health Care, Medical Devices
Compare Puma Biotechnology, Inc. vs Elizabeth Wende Breast Care
Puma Biotechnology, Inc. vs
Marvel Medtech
Marvel Medtech United States

Putting the Preventative in Breast Cancer Treatment

2 employees
Biotechnology, Health Care
Compare Puma Biotechnology, Inc. vs Marvel Medtech
Puma Biotechnology, Inc. vs
Advanced Radiation Therapy
Advanced Radiation Therapy United States

Image-Guided, Non-Invasive Breast Brachytherapy for 5 or 10-day APBI

6 employees
Also compare with: Puma Biotechnology, Inc. vs Aurora Imaging Technology Aurora Imaging Technology

FAQ About Puma Biotechnology, Inc.

At Puma Biotechnology, our focus is on bringing innovative therapies to patients to enhance cancer care.
Puma Biotechnology, Inc. was founded in 2010.
Puma Biotechnology, Inc. is headquartered in Los Angeles, United States.
Puma Biotechnology, Inc. operates in the following industries: Biotechnology, Health and Wellness.
Puma Biotechnology, Inc. has approximately 244 employees.
Puma Biotechnology, Inc. has completed 7 funding rounds, raising a total of $809.30M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Puma Biotechnology, Inc. include Elizabeth Wende Breast Care, Marvel Medtech, Advanced Radiation Therapy, Aurora Imaging Technology, OncoScanner.com. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Puma Biotechnology, Inc. and Elizabeth Wende Breast Care are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Puma Biotechnology, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy